Drugs / IFN-γ 1b
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00753467 | Sep 2008 → Aug 2009 | chronic hepatitis B virus infection | Huntington Medical Research Institutes | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IFN-γ 1b | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00753467 ↗ |
| Modality | Protein / enzyme biologic | “A pilot study has been designed in order to determine the tolerance and effectiveness of recombinant interferon gamma (rIFN-gamma) in chronic hepatitis B virus (HBV) infection.” PMID 2452123 ↗ Feb 1988 |